| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |